InvestorsHub Logo
Followers 2
Posts 425
Boards Moderated 0
Alias Born 10/18/2016

Re: None

Friday, 12/21/2018 4:04:06 PM

Friday, December 21, 2018 4:04:06 PM

Post# of 1742
@bigbill1 I haven't seen Webinar yet but I really liked the press release today. I applaud Nemaura for writing something as thoughtful and concise to give us an idea of where this process is right now,it's empowering to say the least. They obviously reached a decision to raise more capital to move forward with FDA and European launch knowing they wouldn't generate meaningful revenue until late Q1 or early Q2. The revenue generated then will likely go right back into ability to scale up production,next gen and new product trials etc etc I would almost guarantee they've had overtures from suitors but most likely the terms were not nearly as favorable if say they had CE approved and already commercialized product if even partial. I'm looking forward to February 19' when this should certainly be on the cusp of hitting pharmacy shelves. Until then some eoy tax selling is possible at which point I will just add to my position.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NMRD News